Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wencheng Li

Showing results (161-170 of 162) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 162 results.
Molecular Cancer Therapeutics|October 25, 2018
Targeting of Hematologic Malignancies with PTC299, A Novel Potent Inhibitor of Dihydroorotate Dehydrogenase with Favorable Pharmaceutical PropertiesLiangxian Cao, Marla Weetall, Christopher Trotta, et al.
Stroke|August 14, 2020
Characteristics and Outcomes in Patients With COVID-19 and Acute Ischemic Stroke: The Global COVID-19 Stroke RegistryGeorge Ntaios, Patrik Michel, Georgios Georgiopoulos, et al.
Pageof 17

Showing results (161-170 of 162) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 162 results.
Molecular Cancer Therapeutics|October 25, 2018
Targeting of Hematologic Malignancies with PTC299, A Novel Potent Inhibitor of Dihydroorotate Dehydrogenase with Favorable Pharmaceutical PropertiesLiangxian Cao, Marla Weetall, Christopher Trotta, et al.
Stroke|August 14, 2020
Characteristics and Outcomes in Patients With COVID-19 and Acute Ischemic Stroke: The Global COVID-19 Stroke RegistryGeorge Ntaios, Patrik Michel, Georgios Georgiopoulos, et al.
Pageof 17